Back to: IBD Clinical Roadmap 2023
MD Education Ltd 4/4a Bloomsbury Square, London , WC1A 2RP
MD Education USA LLC, 4600 140th Avenue North, Suite 180, Clearwater, Florida 33762
Developed by Unet
UCSF Colitis and Crohn’s Disease Center
Dr. Uma Mahadevan is a gastroenterologist and clinical scientist specializing in inflammatory bowel disease (IBD), particularly pregnancy and drug safety. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, and a fellowship in gastroenterology at the University of California, San Francisco (UCSF). She did an advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF, Director of the UCSF Colitis and Crohn’s Disease Center and Director of the Advanced IBD Fellowship. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.
Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020).
Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan has published over 100 original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, Nature Reviews, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Lancet Gastroenterology Hepatology as well as several book chapters. She authored the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy.
Dr. Mahadevan specializes in the treatment of complex ulcerative colitis and Crohn’s disease. She is a global expert on the management of pregnancy and drug safety in the patient with IBD. She is also interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020 and has developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. This IBD Chat can remotely monitor thousands of patients with IBD and integrate with the existing electronic health record. Additionally, in collaboration with data scientists at UCSF, she is studying ways to answer important questions in IBD using the UCSF electronic health record.
Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who know hold key roles in IBD Centers around the United States.
BWH Crohn’s & Colitis Center
Sonia Friedman, M.D. will join Tufts Medical Center in Boston as Chief of Gastroenterology in March 2023. She has spent the past 23 years at Brigham and Women’s Hospital in Boston where she was a Professor of Medicine at Harvard Medical School. Dr. Friedman completed her undergraduate degree in biology at Stanford University and her MD at Yale Medical School. She did her medical internship and residency at University of Pennsylvania and her gastroenterology fellowship at Mount Sinai Medical Center in New York City. She has received national and international recognition for research and treatment of inflammatory bowel disease. Her research interests include reproductive health and the safety of medications taking during conception and/or during pregnancy in patients with inflammatory bowel disease. Dr. Friedman is a frequent speaker and invited regional, national and international lecturer on the management of inflammatory bowel disease. She has authored or co-authored multiple peer-reviewed papers and is the Deputy Editor of the journal Inflammatory Bowel Diseases. She has received a recent Crohn’s and Colitis Foundation Senior Research Award as well as an American College of Gastroenterology Clinical Research Award to continue her work on reproductive health in inflammatory bowel disease.
UNC School of Medicine
The Dartmouth Institute for Health
Penn Medicine
Vanderbilt IBD Clinic
Northwestern University
Icahn School Of Medicine, Mount Sinai, New York
Northwestern University
Cleveland Clinic
Bharati Kochar is a gastroenterologist and inflammatory bowel disease (IBD) specialist at the Massachusetts General Hospital, Investigator at The Mongan Institute and Assistant Professor of Medicine at Harvard Medical School. After medical school at Brown University, she trained in Internal Medicine at the Johns Hopkins Hospital and did a GI fellowship as well as advanced fellowship in IBD at the University of North Carolina. She also obtained a Master’s of Science in Clinical Research at UNC’s Gillings School of Global Public Health. Dr. Kochar’s research program is interested in advancing the care and quality of life for under-served and under-studied patients with IBD, including older adults. She is funded by the Crohn’s and Colitis Foundation as well as the National Institute of Aging.
Mayo Clinic, Florida
Francis A. Farraye, MD, MSc is Director of the Inflammatory Bowel Disease Center in the Division of Gastroenterology and Hepatology and Professor of Medicine at the Mayo Clinic in Jacksonville, FL. He received his MD from Albert Einstein College of Medicine in New York. He completed an internal medicine residency and gastroenterology fellowship at the Beth Israel Hospital in Boston and a Master’s Degree in Epidemiology from the Harvard School of Public Health. Dr. Farraye has an active academic clinical practice managing patients with Inflammatory Bowel Disease. A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultation in Gastroenterology and co-wrote the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His newest book for patients is Mayo Clinic on Crohn’s Disease and Ulcerative Colitis. He is the Editor in Chief for Inflammatory Bowel Disease Journal Scan published weekly by the ASGE. Dr. Farraye is a Fellow in the ASGE and AGA, and a Master of the American College of Gastroenterology. He has served on numerous national and international committees. The New England Crohn’s and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. In 2020, Dr. Farraye was a recipient of the Lifetime Achievement Award from the New England Crohn’s and Colitis Foundation.
The Dartmouth Institute for Health
Corey A. Siegel, MD, MS, is the Section Chief of Gastroenterology and Hepatology and the Co-Director of the Inflammatory Bowel Disease (IBD) Center at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. He is the Constantine and Joyce Hampers Professor of Medicine and a Professor at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
Dr. Siegel attended college at Tufts University and then received his medical degree from Tufts University School of Medicine in Boston, Massachusetts. He completed his residency in internal medicine at the Dartmouth Hitchcock Medical Center where he also served as chief medical resident. He then completed a fellowship in Gastroenterology at Dartmouth Hitchcock followed by a fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital in Boston.
Dr. Siegel’s research interests include understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, expanding telemedicine services to patients with IBD living in rural locations, and improving the quality of care delivered to patients with IBD. He has been funded by the NIH, AHRQ, the Crohn’s and Colitis Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust for this work. He has lectured nationally and internationally and published numerous journal articles and book chapters on this and other topics in IBD. Dr. Siegel is the founder of the BRIDGe group, an international research collaborative of IBD investigators. He is currently the co-chair of the Crohn’s and Colitis Foundation Quality of Care Program (IBD Qorus). Dr. Siegel was inducted into the International Organization for the Study of IBD (IOIBD) in 2013. He lives in Hanover, New Hampshire with his wife and three boys.
Boston Medical Centre, Massachusetts
Alan C Moss MD, FACG, FEBG, AGAF, FRCPI
Current Academic / Administrative Roles
Director, Crohn’s & Colitis Program, Boston Medical Center
Professor of Medicine, Boston University School of Medicine
Interim Chief, Gastroenterology Section, Boston Medical Center
Education
Prior Academic / Administrative Roles
Key Honors & Awards
Key National / International Committees
Key International Editorial Roles
Academic Publications Summary
Grant Funding History
Brown University
Samir A. Shah, MD, FACG, is a Clinical Professor of Medicine at the Alpert Medical School of Brown University, Chief of Gastroenterology at the Miriam Hospital, and a partner with Gastroenterology Associates Inc in Providence, RI. Dr. Shah earned his BA in Biochemistry magna cum laude at Brown, and his MD at Harvard Medical School in Boston, MA. He did a residency in Internal Medicine at the Harvard-affiliated Beth Israel Deaconess Medical Center and stayed on for a fellowship in Gastroenterology, where he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians and spent two years in the laboratory studying murine models of Inflammatory Bowel Disease. Dr. Shah is the recipient of Brown University’s Teaching Recognition Award, The Dean’s Teaching Excellence Certificate, Brown University’s Excellence in Teaching Award for Clinical Faculty, the Beckwith Family Award for Outstanding Teaching, the ACG’s Freshman Governor’s Award, and the William D. Carey Award. The New England Chapter of the Crohn’s and Colitis Foundation of America named him Humanitarian of the Year for 2009 and co-recipient of the Joan Cutler Lifetime achievement award in 2020. In 2023, he recieved the Lifetime Achievement Award from the DDNC. Rhode Island Monthly magazine consistently names him among the Top Doctors in Rhode Island. He serves as the Physician Lead for his groups’ participation in IBD QORUS, is a Past President of the Digestive Diseases National Coalition (DDNC), faculty for the ACG’s online IBD Circle, and Immediate Past President of the ACG. He has participated in several multi-center clinical trials of cutting-edge therapies for IBD and was co-principal investigator for OSCCAR (Ocean State Crohn’s and Colitis Area Registry).
Cleveland Clinic
Amy Lightner is a Professor of Surgery in the Department of Surgery at Scripps Clinic in San Diego, CA and Chief Medical Office of Direct Biologics, LLC a biotechnology company in Regenerative Medicine. Dr. Lightner received her B.A. in Human Biology from Stanford University, completed her surgical training in General Surgery at University of California at Los Angeles and post-doctoral work at Stanford University under a California Institute of Regenerative Medicine Training Grant focused on the differentiation pathways of embryonic stem cells. After completing her fellowship at Mayo Clinic, she stayed on as surgical faculty, and was the Medical Director for the Center for Regenerative Medicine at Mayo Clinic. She was then recruited to Cleveland Clinic as Associate Professor to focus on complex inflammatory bowel disease, continue her work in translational science and clinical trials, and start a regenerative medicine program. She founded, andwas medical director of the Center for Regenerative Medicine and Surgery at Cleveland Clinic Foundation, and continued her basic science research in stem cell therapy. She isthe PI of six active phase II clinical trials using mesenchymal stem cells for inflammatory bowel disease, has received extramural funding from the Helmsley Foundation, Crohn’s and Colitis Foundation, Cure for IBD, Rainin Foundation and American Society of Colon and Rectal Surgery (ASCRS). She is a member of the editorial board of Inflammatory Bowel Diseases, Colorectal Disease, British Journal of Surgery, Crohn’s and Colitis 360, and Diseases of the Colon and Rectum, the surgical co-chair for the European Crohn’s and Colitis Organization annual meeting, the associate chair of the inflammatory bowel disease committee of ASCRS, vice chair of the national clinical practice guidelines committee for ASCRS, and chair of the surgical research committee for ASCRS.
UCSF Colitis and Crohn’s Disease Center
BWH Crohn’s & Colitis Center
